65399-02-2 Usage
Uses
Used in Pharmaceutical Synthesis:
7-METHYL-2,3-DIHYDROISOINDOLE-1-ONE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can exhibit therapeutic effects.
Used in Organic Compound Production:
As a building block, 7-METHYL-2,3-DIHYDROISOINDOLE-1-ONE is utilized in the production of other chemical compounds, where its unique structure can be incorporated to create novel organic molecules with specific properties.
Used in Medicinal Chemistry:
7-METHYL-2,3-DIHYDROISOINDOLE-1-ONE is employed as a component in medicinal chemistry for its potential to be part of new drug candidates, given its distinctive molecular framework that can be optimized for various biological targets.
Used in Drug Discovery:
In the realm of drug discovery, 7-METHYL-2,3-DIHYDROISOINDOLE-1-ONE is used as a starting point for designing new molecules with therapeutic potential, leveraging its chemical properties to interact with biological systems in innovative ways.
Check Digit Verification of cas no
The CAS Registry Mumber 65399-02-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,9 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 65399-02:
(7*6)+(6*5)+(5*3)+(4*9)+(3*9)+(2*0)+(1*2)=152
152 % 10 = 2
So 65399-02-2 is a valid CAS Registry Number.
65399-02-2Relevant academic research and scientific papers
Chemical oxidation of an anticonvulsant N-(5'-methylisoxazol-3-yl) 2,6- dimethylbenzamide (D2916)
Adolphe-Pierre,Menager,Tombret,Verite,Lepage,Lafont
, p. 513 - 518 (2007/10/03)
The new anticonvulsant N-(5'-methylisoxazol-3-yl)-2,6-dimethylbeazamide (D2916), which presents two kinds of methyl groups which could be oxidized, was submitted to various chemical oxidizing agents. Several sites and degrees of oxidation were observed. The main oxidized site was the arylmethyl group without cleavage of the isoxazole ring, leading via carboxylic acid and primary alcohol intermediates to phthalimide and lactame derivatives. In no case was the methyl group of the isoxazole moiety hydroxylated.
Synthesis of Protected Peptide Fragments and Release from a Solid Support under Neutral Conditions
Osborn, Nigel J.,Robinson, John A.
, p. 2873 - 2884 (2007/10/02)
A linker has been developed for use in solid-phase peptide synthesis which allows a protected peptide to be cleaved from the resin under neutral conditions (nBu3P, DMF, imidazole buffer pH 7) whilst retaining tBuO-, Boc- and Fmoc-protecting groups.The lin
